GlassScriptPhysician profile
Shashank Jain
NPI 1588824007
$17,269.22
in general payments reported to CMS, 2019-2025
29 companies · $2,675 in 2025
The $2,675 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,108 · 2020: $94.84 · 2021: $1,518 · 2022: $2,550 · 2023: $5,066 · 2024: $3,258 · 2025: $2,675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,815 · Food and Beverage: $5,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,815.30 |
| Food and Beverage | $5,184.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,381.85 | 2019-2025 | Triclip, Aveir, Ensite |
| Medtronic, INC. | $3,662.99 | 2021-2024 | Micra, Resolute Onyx, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $2,348.74 | 2019-2024 | Versacross Access Solution, Watchman Flx, Watchman |
| Edwards Lifesciences Corporation | $2,063.85 | 2021-2025 | Pascal, Sapien 3 Ultra Resilia |
| Abiomed | $1,264.44 | 2019-2025 | Impella |
| Inari Medical, INC. | $461.24 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Atricure, INC. | $324.87 | 2021-2023 | |
| Philips North America LLC | $286.22 | 2019-2023 | |
| Biosense Webster, INC. | $276.68 | 2024-2025 | Carto 3 |
| Kestra Medical Technology Services, INC. | $271.55 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $216.69 | 2022-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $171.71 | 2021-2023 | Xarelto |
| Stryker Corporation | $92.18 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $60.27 | 2019-2022 | |
| Davol INC. | $52.51 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $34.83 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.97 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.11 | 2021 | |
| Pfizer INC. | $27.55 | 2020-2022 | |
| Medtronic Vascular, INC. | $26.36 | 2019 | |
| Imperative Care, INC | $25.90 | 2025 | Prodigy Catheter |
| Zoll Respicardia, INC. | $25.72 | 2023 | Remede System |
| Amgen INC. | $23.32 | 2021 | |
| Cvrx, INC. | $22.09 | 2024 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $19.16 | 2024 | Optimizer |
| Cardiovascular Systems INC. | $17.76 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $17.75 | 2019 | |
| Teleflex LLC | $17.56 | 2019 | |
| Chiesi USA, INC. | $13.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shashank Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.